{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:00:20Z","timestamp":1761703220617,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.nwh.2023.06.004","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T01:03:54Z","timestamp":1696467834000},"page":"457-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Supporting the Young Adulthood Transitions in Women With Migraine"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-4700","authenticated-orcid":false,"given":"Brenna L.","family":"Morse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Karian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nwh.2023.06.004_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.719467","article-title":"Lifestyle modifications for migraine management","volume":"13","author":"Agbetou","year":"2022","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.nwh.2023.06.004_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106899","article-title":"Worsening of migraine headache with fasting Ramadan","volume":"209","author":"Al-Hashel","year":"2021","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.nwh.2023.06.004_bib3","article-title":"Americans with Disabilities Act, Public Law 101-336","volume":"42","year":"1990","journal-title":"U.S.C"},{"issue":"10","key":"10.1016\/j.nwh.2023.06.004_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-020-01067-x","article-title":"Management of menstrual migraine","volume":"20","author":"Ansari","year":"2020","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"10283","key":"10.1016\/j.nwh.2023.06.004_bib5","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","article-title":"Migraine: Integrated approaches to clinical management and emerging treatments","volume":"397","author":"Ashina","year":"2021","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.nwh.2023.06.004_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000004228","article-title":"The multispecialty toxin: A literature review of botulinum toxin","volume":"10","author":"Bach","year":"2022","journal-title":"Plastic and Reconstructive Surgery\u2014Global Open"},{"key":"10.1016\/j.nwh.2023.06.004_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2022.100408","article-title":"Migraine in the workplace","volume":"27","author":"Begasse de Dhaem","year":"2022","journal-title":"eNeurologicalSci"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-018-0921-8","article-title":"Guideline on the use of onabotulinumtoxinA in chronic migraine: A consensus statement from the European Headache Federation","volume":"19","author":"Bendtsen","year":"2018","journal-title":"The Journal of Headache and Pain"},{"issue":"5","key":"10.1016\/j.nwh.2023.06.004_bib9","doi-asserted-by":"crossref","DOI":"10.52965\/001c.38534","article-title":"Rimegepant for the treatment of migraine","volume":"10","author":"Berger","year":"2022","journal-title":"Health Psychology Research"},{"issue":"2","key":"10.1016\/j.nwh.2023.06.004_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pds.3920","article-title":"Pregnancy outcomes following exposure to onabotulinumtoxinA","volume":"25","author":"Brin","year":"2016","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/head.14024","article-title":"The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys","volume":"61","author":"Burch","year":"2021","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"7","key":"10.1016\/j.nwh.2023.06.004_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of action of onabotulinumtoxinA in chronic migraine: A narrative review","volume":"60","author":"Burstein","year":"2020","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"8","key":"10.1016\/j.nwh.2023.06.004_bib13","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/head.13613","article-title":"Life with migraine: Effects on relationships, career, and finances from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study","volume":"59","author":"Buse","year":"2019","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/head.14451","article-title":"The role of avoiding known triggers, embracing protectors, and adhering to healthy lifestyle recommendations in migraine prophylaxis: Insights from a prospective cohort of 1125 people with episodic migraine","volume":"63","author":"Casanova","year":"2023","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"Suppl 1","key":"10.1016\/j.nwh.2023.06.004_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10072-012-1030-0","article-title":"Migraine and sleep disorders","volume":"33","author":"Cevoli","year":"2012","journal-title":"Neurological Sciences"},{"issue":"5","key":"10.1016\/j.nwh.2023.06.004_bib16","doi-asserted-by":"crossref","first-page":"489.e1","DOI":"10.1016\/j.ajog.2016.12.019","article-title":"Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke","volume":"216","author":"Champaloux","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"12","key":"10.1016\/j.nwh.2023.06.004_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jamapediatrics.2022.3948","article-title":"Migraine and mental health in pediatrics","volume":"176","author":"Chatterjee","year":"2022","journal-title":"JAMA Pediatrics"},{"issue":"4","key":"10.1016\/j.nwh.2023.06.004_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/17579139211016077","article-title":"Associations of loneliness and social isolation with physical and mental health among adolescents and young adults","volume":"141","author":"Christiansen","year":"2021","journal-title":"Perspectives in Public Health"},{"issue":"10200","key":"10.1016\/j.nwh.2023.06.004_bib19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: A randomised, phase 3, double-blind, placebo-controlled trial","volume":"394","author":"Croop","year":"2019","journal-title":"The Lancet"},{"issue":"10268","key":"10.1016\/j.nwh.2023.06.004_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","article-title":"Oral rimegepant for preventive treatment of migraine: A phase 2\/3, randomised, double-blind, placebo-controlled trial","volume":"397","author":"Croop","year":"2021","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.nwh.2023.06.004_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/14737175.2020.1772758","article-title":"Targeting CGRP for migraine treatment: Mechanisms, antibodies, small molecules, perspectives","volume":"20","author":"De Matteis","year":"2020","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-017-0764-8","article-title":"Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: An observational study in a tertiary headache center","volume":"18","author":"de Tommaso","year":"2017","journal-title":"The Journal of Headache and Pain"},{"issue":"7","key":"10.1016\/j.nwh.2023.06.004_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0333102414566820","article-title":"Systematic re-evaluation of genes from candidate gene association studies in migraine using a large genome-wide association data set","volume":"36","author":"de Vries","year":"2016","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.nwh.2023.06.004_bib24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/14656566.2021.1895749","article-title":"Evaluating rimegepant for the treatment of migraine","volume":"22","author":"de Vries","year":"2021","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.nwh.2023.06.004_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.maturitas.2020.12.012","article-title":"Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman\u2019s life: Implications for the efficacy and safety of novel antimigraine medications","volume":"145","author":"de Vries Lentsch","year":"2021","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.nwh.2023.06.004_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1060028020954800","article-title":"Rimegepant orally disintegrating tablet for acute migraine treatment: A review","volume":"55","author":"DeFalco","year":"2021","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.nwh.2023.06.004_bib27","series-title":"Monoclonal antibodies in headache","first-page":"121","article-title":"Erenumab","author":"Do","year":"2021"},{"issue":"23","key":"10.1016\/j.nwh.2023.06.004_bib28","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the treatment of migraine","volume":"381","author":"Dodick","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.nwh.2023.06.004_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","article-title":"Diagnosis and management of migraine in ten steps","volume":"17","author":"Eigenbrodt","year":"2021","journal-title":"Nature Reviews Neurology"},{"issue":"S1","key":"10.1016\/j.nwh.2023.06.004_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10072-019-03837-z","article-title":"Sleep disorder-related headaches","volume":"40","author":"Ferini-Strambi","year":"2019","journal-title":"Neurological Sciences"},{"issue":"2","key":"10.1016\/j.nwh.2023.06.004_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/0309877X.2022.2102416","article-title":"Housing conditions and psychological distress among higher education students: A systematic literature review","volume":"47","author":"Franzoi","year":"2023","journal-title":"Journal of Further and Higher Education"},{"key":"10.1016\/j.nwh.2023.06.004_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01577","article-title":"Efficacy and safety of rimegepant for the acute treatment of migraine: Evidence from randomized controlled trials","volume":"10","author":"Gao","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"8","key":"10.1016\/j.nwh.2023.06.004_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255634","article-title":"Gender differences in perceived stress and coping among college students","volume":"16","author":"Graves","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.nwh.2023.06.004_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2018.02780","article-title":"Coping with depressive symptoms in young adults: Perceived social support protects against depressive symptoms only under moderate levels of stress","volume":"9","author":"Ioannou","year":"2019","journal-title":"Frontiers in Psychology"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.spen.2016.02.001","article-title":"Medical comorbidities in pediatric headache","volume":"23","author":"Jacobs","year":"2016","journal-title":"Seminars in Pediatric Neurology"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/14737167.2021.1945444","article-title":"Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: A network meta-analysis","volume":"22","author":"Johnston","year":"2022","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"key":"10.1016\/j.nwh.2023.06.004_bib37","series-title":"Getting ahead of pediatric headaches","first-page":"142","article-title":"Moving into adulthood, college and beyond","author":"Karian","year":"2020"},{"key":"10.1016\/j.nwh.2023.06.004_bib38","article-title":"OnabotulinumtoxinA for pediatric migraine. Pain Management Nursing","author":"Karian","year":"2023","journal-title":"Advance online publication"},{"key":"10.1016\/j.nwh.2023.06.004_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.613372","article-title":"The migraine\u2013anxiety comorbidity among migraineurs: A systematic review","volume":"11","author":"Karimi","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.nwh.2023.06.004_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jocn.2020.05.034","article-title":"Association of drinking water and migraine headache severity","volume":"77","author":"Khorsha","year":"2020","journal-title":"Journal of Clinical Neuroscience"},{"issue":"10","key":"10.1016\/j.nwh.2023.06.004_bib41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1177\/0333102419840780","article-title":"A\u00a0new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody","volume":"39","author":"Kielbasa","year":"2019","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-017-0756-8","article-title":"Insufficient sleep is prevalent among migraineurs: A population-based study","volume":"18","author":"Kim","year":"2017","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.nwh.2023.06.004_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113514","article-title":"Stress, self-compassion, and well-being during the transition to college","volume":"269","author":"Kroshus","year":"2021","journal-title":"Social Science & Medicine"},{"issue":"10","key":"10.1016\/j.nwh.2023.06.004_bib44","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/acer.14157","article-title":"Unpacking genetic risk pathways for college student alcohol consumption: The mediating role of impulsivity","volume":"43","author":"Ksinan","year":"2019","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"3","key":"10.1016\/j.nwh.2023.06.004_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0333102417739584","article-title":"Gender aspects of CGRP in migraine","volume":"39","author":"Labastida-Ram\u00edrez","year":"2019","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/head.14234","article-title":"Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15\u00a0months of galcanezumab treatment","volume":"62","author":"L\u00e1inez","year":"2022","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"8","key":"10.1016\/j.nwh.2023.06.004_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-020-00869-5","article-title":"Pediatric migraine and academics","volume":"24","author":"Langdon","year":"2020","journal-title":"Current Pain and Headache Reports"},{"issue":"4","key":"10.1016\/j.nwh.2023.06.004_bib48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1358\/dot.2019.55.4.2970909","article-title":"Fremanezumab for the prevention of chronic and episodic migraine","volume":"55","author":"Lionetto","year":"2019","journal-title":"Drugs of Today"},{"issue":"19","key":"10.1016\/j.nwh.2023.06.004_bib49","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.2019.16711","article-title":"Effect of ubrogepant vs\u00a0placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: The ACHIEVE II randomized clinical trial","volume":"322","author":"Lipton","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.nwh.2023.06.004_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00127-019-01726-6","article-title":"Gender differences in the influence of social isolation and loneliness on depressive symptoms in college students: A longitudinal study","volume":"55","author":"Liu","year":"2020","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"2","key":"10.1016\/j.nwh.2023.06.004_bib51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jamaneurol.2018.4141","article-title":"Consideration of costs and open-label studies of erenumab: Reply","volume":"76","author":"Loder","year":"2019","journal-title":"JAMA Neurology"},{"issue":"6","key":"10.1016\/j.nwh.2023.06.004_bib52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/job.2651","article-title":"Gender differences in the relationship between presenteeism and extra-role behaviors","volume":"44","author":"Luksyte","year":"2023","journal-title":"Journal of Organizational Behavior"},{"issue":"12","key":"10.1016\/j.nwh.2023.06.004_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-018-0734-0","article-title":"Triggers, protectors, and predictors in episodic migraine","volume":"22","author":"Marmura","year":"2018","journal-title":"Current Pain and Headache Reports"},{"issue":"4","key":"10.1016\/j.nwh.2023.06.004_bib54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.fertnstert.2017.12.016","article-title":"Prevalence of migraines in adolescents with endometriosis","volume":"109","author":"Miller","year":"2018","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.nwh.2023.06.004_bib55","series-title":"Headache and migraine in practice","first-page":"161","article-title":"Medication overuse headache","author":"Mohammadianinejad","year":"2022"},{"issue":"9","key":"10.1016\/j.nwh.2023.06.004_bib56","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0333102420938652","article-title":"Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache","volume":"40","author":"Navratilova","year":"2020","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.nwh.2023.06.004_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13543784.2019.1618830","article-title":"Gepants for the treatment of migraine","volume":"28","author":"Negro","year":"2019","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"4","key":"10.1016\/j.nwh.2023.06.004_bib58","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/ene.13861","article-title":"Alcoholic beverages as trigger factor and the effect on alcohol consumption behavior in patients with migraine","volume":"26","author":"Onderwater","year":"2019","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-019-1054-4","article-title":"The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: A critical appraisal","volume":"20","author":"Ornello","year":"2019","journal-title":"The Journal of Headache and Pain"},{"issue":"8","key":"10.1016\/j.nwh.2023.06.004_bib60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40263-021-00834-9","article-title":"Indirect comparison of topiramate and monoclonal antibodies against CGRP or its receptor for the prophylaxis of episodic migraine: A systematic review with meta-analysis","volume":"35","author":"Overeem","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib61","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-019-0743-7","article-title":"Migraine: Stigma in society","volume":"23","author":"Parikh","year":"2019","journal-title":"Current Pain and Headache Reports"},{"key":"10.1016\/j.nwh.2023.06.004_bib62","series-title":"Monoclonal antibodies in headache","first-page":"99","article-title":"Galcanezumab","author":"Reuter","year":"2021"},{"issue":"12","key":"10.1016\/j.nwh.2023.06.004_bib63","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11916-022-01095-x","article-title":"Legal aspects of migraine in the workplace","volume":"26","author":"Riggins","year":"2022","journal-title":"Current Pain and Headache Reports"},{"key":"10.1016\/j.nwh.2023.06.004_bib64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/NDT.S371686","article-title":"Review of tolerability of fremanezumab for episodic and chronic migraine","volume":"19","author":"Root","year":"2023","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11033-021-06799-8","article-title":"Is there any association between migraine headache and polycystic ovary syndrome (PCOS)? A review article","volume":"49","author":"Sarahian","year":"2022","journal-title":"Molecular Biology Reports"},{"issue":"3","key":"10.1016\/j.nwh.2023.06.004_bib66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s40265-020-01264-5","article-title":"Ubrogepant: First approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib67","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40271-021-00525-z","article-title":"Patient perspectives and experiences of preventive treatments and self-injectable devices for migraine: A focus group study","volume":"15","author":"Seo","year":"2022","journal-title":"The Patient\u2014Patient-Centered Outcomes Research"},{"issue":"9","key":"10.1016\/j.nwh.2023.06.004_bib68","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1111\/head.13913","article-title":"What will it take to move the needle for headache disorders? An advocacy perspective","volume":"60","author":"Shapiro","year":"2020","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/maj.2002.121958","article-title":"Clinical results of botulinum toxin type A treatment of migraine headache","volume":"22","author":"Silberstein","year":"2002","journal-title":"Aesthetic Surgery Journal"},{"issue":"12","key":"10.1016\/j.nwh.2023.06.004_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121180","article-title":"Pharmacokinetics, pharmacodynamics and drug\u2013drug interactions of new anti-migraine drugs\u2014lasmiditan, gepants, and calcitonin-gene-related peptide (CGRP) receptor monoclonal antibodies","volume":"12","author":"Szkutnik-Fiedler","year":"2020","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.nwh.2023.06.004_bib71","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.13091","article-title":"Migraine in children","volume":"57","author":"Tepper","year":"2017","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"8","key":"10.1016\/j.nwh.2023.06.004_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-017-0463-4","article-title":"Anti-CGRP monoclonal antibodies: The next era of migraine prevention?","volume":"19","author":"Tso","year":"2017","journal-title":"Current Treatment Options in Neurology"},{"year":"2021","series-title":"Highlights of prescribing information: BOTOX (onabotulinumtoxinA)","key":"10.1016\/j.nwh.2023.06.004_bib73"},{"issue":"6","key":"10.1016\/j.nwh.2023.06.004_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/0333102420974362","article-title":"Sex differences in prevalence of migraine trigger factors: A cross-sectional study","volume":"41","author":"van Casteren","year":"2021","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-021-01335-2","article-title":"CGRP monoclonal antibodies in migraine: An efficacy and tolerability comparison with standard prophylactic drugs","volume":"22","author":"Vandervorst","year":"2021","journal-title":"The Journal of Headache and Pain"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/head.14027","article-title":"Migraine diagnosis and treatment: A knowledge and needs assessment of women\u2019s healthcare providers","volume":"61","author":"Verhaak","year":"2021","journal-title":"Headache: The Journal of Head and Face Pain"},{"issue":"3","key":"10.1016\/j.nwh.2023.06.004_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14737175.2020.1715212","article-title":"Mindfulness in migraine: A narrative review","volume":"20","author":"Wells","year":"2020","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0333102415578430","article-title":"Medication overuse, healthy lifestyle behaviour and stress in chronic headache: Results from a population-based representative survey","volume":"36","author":"Westergaard","year":"2016","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.nwh.2023.06.004_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-020-01196-1","article-title":"OnabotulinumtoxinA for chronic migraine during pregnancy: A real world experience on 45 patients","volume":"21","author":"Wong","year":"2020","journal-title":"The Journal of Headache and Pain"},{"key":"10.1016\/j.nwh.2023.06.004_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.00028","article-title":"The efficacy and safety of topiramate in the prevention of pediatric migraine: An update meta-analysis","volume":"8","author":"Wu","year":"2020","journal-title":"Frontiers in Pediatrics"},{"issue":"5","key":"10.1016\/j.nwh.2023.06.004_bib81","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40263-019-00626-2","article-title":"A\u00a0multi-center, open-label, pharmacokinetic drug interaction study of erenumab and a combined oral contraceptive in healthy females","volume":"33","author":"Xu","year":"2019","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.nwh.2023.06.004_bib82","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40263-020-00715-7","article-title":"Safety and efficacy of ubrogepant for the acute treatment of episodic migraine: A meta-analysis of randomized clinical trials","volume":"34","author":"Yang","year":"2020","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.nwh.2023.06.004_bib83","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1111\/jcmm.14390","article-title":"The exploration of mechanisms of comorbidity between migraine and depression","volume":"23","author":"Zhang","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"11","key":"10.1016\/j.nwh.2023.06.004_bib84","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-021-00983-y","article-title":"The psychiatric comorbidities of migraine in children and adolescents","volume":"25","author":"Ziplow","year":"2021","journal-title":"Current Pain and Headache Reports"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485123001988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485123001988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:44:25Z","timestamp":1761687865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485123001988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1751485123001988"],"URL":"https:\/\/doi.org\/10.1016\/j.nwh.2023.06.004","relation":{},"ISSN":["1751-4851"],"issn-type":[{"type":"print","value":"1751-4851"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supporting the Young Adulthood Transitions in Women With Migraine","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nwh.2023.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AWHONN","name":"copyright","label":"Copyright"}]}}